AHFS DI Monographs
AHFS DI from the American Society of Health-System Pharmacists' (ASHP) is the most comprehensive source of unbiased and authoritative drug information available to health professionals today. A wholly independent staff of drug information pharmacists and other professional editorial and analytical staff thoroughly research AHFS DI content. Authors incorporate clinical research findings, therapeutic guidelines, and Food and Drug Administration (FDA) approved labeling to ensure that monographs include an evidence-based foundation for safe and effective drug therapy.
About AHFS DI Monographs
The U.S. Congress and various health care insurance providers have also recognized the authority of the AHFS DI information on the medically accepted uses of drugs. AHFS DI has been listed by the American College of Physicians-American Society of Internal Medicine as a standard item for inclusion in reference libraries and has been a required drug reference for pharmacies in most states. The publication’s longstanding policy of editorial independence from the influence of pharmaceutical manufacturers, health insurers, pharmacy benefit managers, and other third parties has been formalized in an official statement approved by the ASHP Board of Directors.
Monographs include the recommendations of numerous authorities, including the U.S. Centers for Disease Control and Prevention, the American Heart Association, the Institute of Medicine of the National Academies, the Women’s Health Initiative and many others. The publication also features major cautionary information from FDA MedWatch notices as well as new and updated scientific findings.
- A1-Proteinase Inhibitor → Antithymocyte Globulin (Equine)
- Antithymocyte Globulin (Rabbit) → Aztreonam